JamesDLevineMD

Hematology • Boston, MA

Myeloproliferative Disorder Hematology-Oncology

Assistant Professor of Medicine, Beth Israel Deaconess Medical Center

Join to view full profile

Dr. Levine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levine's full profile

Already have an account?

Office
330 Brookline Ave
Scc913
Boston, MA 02215
Phone+1 617-667-9235

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1979 - 1982
University of California (San Francisco)Residency, Internal Medicine, 1977 - 1979
Detroit Medical Center/Wayne State University (Sinai Grace)Internship, Internal Medicine, 1976 - 1977
University of California San Francisco School of MedicineClass of 1976
University of CaliforniaMS, Medical Sciences, 1972 - 1974
University of California, BerkeleyBA, Biochemistry, 1970 - 1972

Certifications & Licensure

CA State Medical License 1977 - Present
MA State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Phase 3
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Start of enrollment: 2011 Sep 01
Terminated
Phase 1
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Completed
Phase 3

Publications & Presentations

PubMed

129 citations
Lenalidomide enhances anti-myeloma cellular immunity
Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Dina Stroopinsky
Cancer Immunology, Immunotherapy. 2013-01-01
156 citations
Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, Lynne Uhl, Nikhil C. Munshi
Clinical Cancer Research. 2013-07-01
157 citations
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, Simona Blotta, Claire MacNamara
Blood. 2011-01-13